- 38 次围观
产品图片
货号/SKU
NR-43942
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
NR-43942?? Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Hong Kong/ 33982/2009 (H9N2) (antiserum, Goat)(Polyclonal Antiserum)|Influenza A virus|Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Hong Kong/ 33982/2009 (H9N2) (antiserum, Goat)|-20°C to -40°C|St. Jude Children's Research Hospital (CEIRS)Acknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Polyclonal Anti-Influenza Virus H9 Hemagglutinin (HA), A/Hong Kong/33982/2009 (H9N2) (antiserum, Goat), NR-34798."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Antiserum to the H9 hemagglutinin (HA) from influenza virus was produced by immunization of a goat with baculovirus expressed recombinant HA protein from influenza A/Hong Kong/33982/2009 (H9N2).
Each vial contains approximately 500 ?L goat polyclonal antiserum, lyophilized.
NR-43942 is specific to the H9 HA of influenza virus as determined in serological hemagglutinin inhibition (HI) assays. Note: Treatment with 6 parts of receptor destroying enzyme (RDE; Denka Seiken Co., LTD) in PBS to 1 part sera to 3 parts 1.5% sodium citrate at 56°C for 120 minutes is needed to remove non-specific inhibitors of hemagglutination. Specificity may be adversely affected without treatment. This represents twice as much RDE and twice the treatment time as is typically required to achieve specificity. Applications: HI, Western blot, immunoprecipitation, virus neutralization test.
Antiserum to the H9 hemagglutinin (HA) from influenza virus was produced by immunization of a goat with baculovirus expressed recombinant HA protein from influenza A/Hong Kong/33982/2009 (H9N2).
Each vial contains approximately 500 ?L goat polyclonal antiserum, lyophilized.
NR-43942 is specific to the H9 HA of influenza virus as determined in serological hemagglutinin inhibition (HI) assays. Note: Treatment with 6 parts of receptor destroying enzyme (RDE; Denka Seiken Co., LTD) in PBS to 1 part sera to 3 parts 1.5% sodium citrate at 56°C for 120 minutes is needed to remove non-specific inhibitors of hemagglutination. Specificity may be adversely affected without treatment. This represents twice as much RDE and twice the treatment time as is typically required to achieve specificity. Applications: HI, Western blot, immunoprecipitation, virus neutralization test.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送到NIAID. 来自流感病毒的H9 H9血凝素(HA)的抗血清是通过从流感的重组HA蛋白免疫山羊产生的山羊生物A / Hong Kong / 33982/2009(H9N2). 每个小瓶含有大约500μl的山羊多克隆抗血清,冻干. NR-43942特异于血清学??血凝素抑制(HI)测定中测定的流感病毒的H9公顷. 注意:用6份受体破坏酶(RDE; DENKA SEIKEN有限公司)在PBS中进行治疗,以1份血清为3份1.5%柠檬酸钠,需要120分钟.去除血凝的非特异性抑制剂.没有治疗可能会受到不利影响的特异性.这代表了两倍的RDE和达到特异性所需的治疗时间的两倍. 应用:HI,Western印迹,免疫沉淀,病毒中和试验.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-03-31
2022-04-01
2021-12-21
2021-12-13
2021-12-21
2024-05-19
2022-04-01
2024-05-19
2021-12-02
2022-04-01
2024-05-19
2022-04-01
2019-05-08
2021-12-21
2024-06-03